ABC Arthritis



Search:

Anklosing Spondylitis

Arthritis Resources & Information
Would you like to
contribute to this site?

Arthritis Menu

Submit an Article
Submit a Tip
Place your Ad
Add URL
Arthritis Questions?
Contact Us


Related Topics:

Anklosing Spondylitis
Ankylosing Spondylitis
Ankylosing Spondylitis Diagnosis
Ankylosing Spondylitis Disease
What Is Ankylosing Spondylitis



Other Channels:

 Rheumatoid Diseases 
 Arthritis Symptoms 
 Arthritis Causes 
 Arthritis Pain 
 Joint Pain Information 
 Joint Pain Locations 
 Arthritis Pain Relief 
 Arthritis Body Spots 
 Hip Arthritis 
 Knee Arthritis 
 Finger Arthritis 
 Hand Arthritis 
 Types Of Arthritis 
 Rheumatoid Arthritis 
 Psoriatic Arthritis 
 Osteoarthritis 
 Juvenile Arthritis 
 Lupus Arthritis 
 Ankylosing Spondylitis 
 Rheumatism 
 Arthritis Treatments 
 Arthritis Exercises 
 Arthritis Medication 
 Glucosamine Chondroitin 
 Natural Arthritis Treatment 
 Diet To Help Arthritis 
 Alternative Arthritis Treatment 
 Arthritis Remedies 
 Arthritis Home Remedies 
 Types Of Arthritis Treatment 
 Arthritis In Animals 
 Arthritis Resources 
 Support For Arthritis 
 Arthritis Pictures 
 Arthritis Information 
Category Leaders: Anklosing Spondylitis
Recent Questions and Answers
Recent Anklosing Spondylitis News:  
Ankylosing Spondylitis - Bing News

AstraZeneca Submits Marketing Authorisation Application to European ... - pressreleasepoint.com
AstraZeneca and POZEN Inc. today announced that they have submitted a Marketing Authorisation Application (MAA) in the European Union via the Decentralised Procedure (DCP) for VIMOVO™ (enteric-coated naproxen/immediate release esomeprazole ...

Johnson & Johnson (JNJ) Subsidiary Centocor Bio Announces Positive ... - StreetInsider.com
Johnson & Johnson's (NYSE: JNJ ) Centocor Ortho Biotech today announced that new long-term data from two pivotal, Phase 3 clinical trials showed that patients with active rheumatoid arthritis receiving SIMPONI (golimumab) every four weeks achieved ...

AstraZeneca, Pozen Say Six-month Trials Show Vimovo Lowers NSAID ... - RTT News
(RTTNews) - Monday, drug makers AstraZeneca plc (AZN: News ) and POZEN Inc. (POZN: News ) said two six-month clinical trials involving Vimovo, an investigational drug co-developed by the companies for various types of arthritis, demonstrated that ...

Lawyers wrestle with inmate's arthritis - Deseret News
It's easy. Send a link to the story you were just reading to a friend. Just fill out the form on this page and we'll send it along. Curtis Michael Allgier, who is charged with killing a corrections officer and could face the death penalty if ...

Another tnf blocking agent? - Gerson Lehrman Group
Cimzia is another good option for patients with significant RA. Its clinical usage is similar to other TNF blockers, except longer half life, so less shots required. Once a month dosing is nice, but no difference in efficacy or side effects. Approved ...

Clickbank Data Feeds
Ways to Make Extra Money
 
Additional Anklosing Spondylitis Resources:  

1. Ankylosing Spondylitis: Understanding Systemic Arthritis ...
Ankylosing spondylitis is a systemic autoimmune disease affecting the joints,
heart, lungs, bowels and eyes.


2. KickAS.org - #1 AS support site in the world
As suggested in this post by one of our members, the KickAS forums are much more
than just another Ankylosing Spondylitis resource. ...


3. anklosing spondylitis
Information on Anklosing Spondylitis. ... Anklosing Spondylitis. I am 55 now.
When I started this web site I was 51 and had been diagnosed with AS about 11
...


4. Anklosing Spondylitis
Ankylosing spondylitis is a chronic disease that often causes inflammation in
the ... Anklosing spondylitis is a common misspelling of ankylosing spondylitis.



Want your site featured on this page?
 

Want your site featured on this targeted page?


Get your Arthritis questions answered... Subscribe to our
Arthritis
Newsletter FREE!

Your First Name:

Your Email Address:



Enter above security code





Arthritis Partner Sites
Copyright © ABCArthritis.com, 2009. All rights reserved.
Contact Us | Privacy Policy | Terms of Use